15/10/02说明：此前论坛服务器频繁出错，现已更换服务器。今后论坛继续数据库备份，不备份上传附件。

肝胆相照论坛

注册

找回密码

 

 

肝胆相照论坛 › 论坛 › 学术讨论& HBV English › 存档 1 › E+患者48周治疗并停药后的持续反应：3期24周ETV跟踪(200 ...
查看: 436|回复: 1

E+患者48周治疗并停药后的持续反应：3期24周ETV跟踪(2005.4.23) [复制链接]

zasxz

Rank: 7Rank: 7Rank: 7

现金
3700 元 
精华
16 
帖子
1790 
注册时间
2002-12-9 
最后登录
2021-4-14 

旺旺勋章 大财主勋章 如鱼得水 黑煤窑矿工勋章

1楼
发表于 2005-4-24 23:41

Sustained Response Off-treatment to Entecavir and Lamivudine after 48 Weeks of Treatment in Nucleoside na飗e, HBeAg (+) Patients: 24- week Follow-up Results of Phase 3 Study ETV-022?br>

Over 70% of patients with CR after 48 weeks of ETV therapy sustained their responses off-treatment through 24 weeks. By suppressing HBV DNA, causing loss of HBeAg, and reducing ALT levels with 1 year of treatment, ETV has the potential to sustain a complete response (CR) when therapy is discontinued.

http://www.medhelp.org/user_photos/show/154916?personal_page_id=1697291
zasxz

Rank: 7Rank: 7Rank: 7

现金
3700 元 
精华
16 
帖子
1790 
注册时间
2002-12-9 
最后登录
2021-4-14 

旺旺勋章 大财主勋章 如鱼得水 黑煤窑矿工勋章

2楼
发表于 2005-4-24 23:41

Reference R G Gish and others. Abstract 490. 40th EASL. April 13-17, 2005. Paris, France.?/font>
http://www.medhelp.org/user_photos/show/154916?personal_page_id=1697291
‹ 上一主题|下一主题 ›
返回列表

肝胆相照论坛

GMT+8, 2024-10-7 15:26 , Processed in 0.012490 second(s), 12 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.